ArticleMaterials today. Bio2022

Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer.

Zhicheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.